Evidence map›Paper›PMID 27698473›Full record

ArticleScientific reports2016

Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state.

Silvia Cellone Trevelin, Célio Xavier Dos Santos, Raphael Gomes Ferreira, Larissa de Sá Lima, Rangel Leal Silva, Cristoforo Scavone, Rui Curi, José Carlos Alves-Filho, Thiago Mattar Cunha, Pérsio Roxo-Júnior and 9 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Redox protection by bacterial glutathione peroxidase drives virulence inRedox report : communications in free radical research · 2026
    Article
  2. Article
  3. Article
  4. Selenium and Selenoproteins in Neutrophil Functions.Biological trace element research · 2026
    Review
  5. Review
  6. Reductive stress in cancer immunology and targeted therapy.Acta biochimica et biophysica Sinica · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. NADPCurrent medicinal chemistry · 2025
    Review
  11. MnTheranostics · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Functions of ROS in Macrophages and Antimicrobial Immunity.Antioxidants (Basel, Switzerland) · 2021
    Review
  17. Review
  18. From Flies to Men: ROS and the NADPH Oxidase in Phagocytes.Frontiers in cell and developmental biology · 2021
    Review
  19. Reactive Oxygen Species: Not Omnipresent but Important in Many Locations.Frontiers in cell and developmental biology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Silvia Cellone TrevelinDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Célio Xavier Dos SantosKing's College London, British Heart Foundation Centre, Cardiovascular Division, London, United Kingdom.
Raphael Gomes FerreiraDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Larissa de Sá LimaDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Rangel Leal SilvaDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Cristoforo ScavoneDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Rui CuriDepartment of Biophysics and Physiology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
José Carlos Alves-FilhoDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Thiago Mattar CunhaDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Pérsio Roxo-JúniorDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Maria-Célia CerviDepartment of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Francisco Rafael Martins LaurindoHeart Institute, School of Medicine, University of Sao Paulo, São Paulo, Brazil.
John Stephen HothersallDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Andrew M CobbKing's College London, British Heart Foundation Centre, Cardiovascular Division, London, United Kingdom.
Min ZhangKing's College London, British Heart Foundation Centre, Cardiovascular Division, London, United Kingdom.
Aleksandar IveticKing's College London, British Heart Foundation Centre, Cardiovascular Division, London, United Kingdom.
Ajay M ShahKing's College London, British Heart Foundation Centre, Cardiovascular Division, London, United Kingdom.
Lucia Rossetti LopesDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, São Paulo, Brazil.
Fernando Queiroz CunhaDepartment of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
Universidade de São Paulo · BRKing's College London · GBBritish Heart Foundation · GB

Funding

British Heart Foundation RG/13/11/30384Department of Health
6 · The paper itself

Abstract

The reactive-oxygen-species-(ROS)-generating-enzyme Nox2 is essential for leukocyte anti-microbial activity. However its role in cellular redox homeostasis and, consequently, in modulating intracellular signaling pathways remains unclear. Herein, we show Nox2 activation favors thioredoxin-1 (TRX-1)/p40phox interaction, which leads to exclusion of TRX-1 from the nucleus. In contrast, the genetic deficiency of Nox2 or its pharmacological inhibition with apocynin (APO) results in reductive stress after lipopolysaccharide-(LPS)-cell stimulation, which causes nuclear accumulation of TRX-1 and enhanced transcription of inflammatory mediators through nuclear-factor-(NF)-κB. The NF-κB overactivation is prevented by TRX-1 oxidation using inhibitors of thioredoxin reductase-1 (TrxR-1). The Nox2/TRX-1/NF-κB intracellular signaling pathway is involved in the pathophysiology of chronic granulomatous disease (CGD) and sepsis. In fact, TrxR-1 inhibition prevents nuclear accumulation of TRX-1 and LPS-stimulated hyperproduction of tumor-necrosis-factor-(TNF)-α by monocytes and neutrophils purified from blood of CGD patients, who have deficient Nox2 activity. TrxR-1 inhibitors, either lanthanum chloride (LaCl

Indexed as

AcetophenonesAnimalsGranulomatous Disease, ChronicLipopolysaccharidesMaleMiceMice, KnockoutNADPH Oxidase 2NF-kappa BOxidation-ReductionSepsisSignal TransductionThioredoxinsAcetophenonesacetovanilloneCybb protein, mouseLipopolysaccharidesNADPH Oxidase 2NF-kappa BThioredoxinsTxn1 protein, mouse

Identifiers

PMID27698473
PMCPMC5048297
OpenAlexW2529420856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.